Antibody Discovery Market Size, Share, Growth & Industry Analysis, By Technique (Phage, Display Technology, Single B Cell Immunization, Hybridoma Technology & Others), By Antibody Type (Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody), By End-User, and Regional Analysis, 2024-2031

TABLE OF CONTENT

1 INTRODUCTION OF THE GLOBAL ANTIBODY DISCOVERY MARKET 
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 Data Collection
3.1.1 Secondary Sources
3.1.2 Primary Sources
3.1.3 Research Flow
3.2 Subject Matter Expert Advice
3.3 Quality Check
3.4 Final Review
3.5 Bottom-Up Approach
3.6 Top-down Approach

4 GLOBAL ANTIBODY DISCOVERY MARKET OUTLOOK
4.1 Market Evolution
4.2 Overview
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.3.4 Challenges
4.4 Pricing Analysis
4.5 Porter’s Five Forces Analysis
4.6 Value Chain Analysis
4.7 Macroeconomic Analysis

5 IMPACT OF RUSSIA-UKRAINE WAR

6 GLOBAL ANTIBODY DISCOVERY MARKET, BY TECHNIQUE
6.1 Overview
6.2 Phage Display Technology
6.3 Single B Cell Immunization
6.4 Hybridoma Technology
6.5 Next-generation Sequencing (NGS)
6.6 RT-PCR
6.7 Flow Cytometry
6.8 Fluorescence-activated Cell Sorting (FACS) 

7 GLOBAL ANTIBODY DISCOVERY MARKET, BY ANTIBODY TYPE
7.1 Overview
7.2 Humanized Antibody
7.3 Human Antibody
7.4 Chimeric Antibody
7.5 Murine Antibody 

8 GLOBAL ANTIBODY DISCOVERY MARKET, BY END-USER
8.1 Overview
8.2 Pharmaceutical & Biotechnology Companies
8.3 Research & Academic Laboratories  

9 GLOBAL ANTIBODY DISCOVERY MARKET, BY GEOGRAPHY
9.1 Overview

10 NORTH AMERICA 
10.1 U.S.
10.2 Canada
10.3 Mexico

11 EUROPE 
11.1 Germany
11.2 U.K.
11.3 France
11.4 Italy
11.5 Spain
11.6 Russia
11.7 Rest of Europe

12 ASIA-PACIFIC 
12.1 China
12.2 Japan
12.3 India
12.4 South Korea
12.5 Rest of Asia-Pacific

13 MIDDLE EAST & AFRICA 
13.1 GCC
13.2 South Africa
13.3 North Africa
13.4 Rest of Middle East & Africa

14 LATIN AMERICA 
14.1 Brazil
14.2 Argentina
14.3 Rest of South America

15 GLOBAL ANTIBODY DISCOVERY MARKET COMPETITIVE LANDSCAPE
15.1 Overview
15.2 Key Developments
15.3 Key Strategic Developments
15.4 Company Market Ranking
15.5 Regional Footprint
15.6 Industry Footprint

16 COMPANY PROFILES
16.1 Eurofins Discovery
16.1.1 Key Facts
16.1.2 Financial Overview
16.1.3 Product Benchmarking
16.1.4 Recent Developments
16.1.5 Winning Imperatives
16.1.6 Current Focus & Strategies
16.1.7 Threat from competition
16.1.8 SWOT Analysis
16.2 Evotec
16.2.1 Key Facts
16.2.2 Financial Overview
16.2.3 Product Benchmarking
16.2.4 Recent Developments
16.2.5 Winning Imperatives
16.2.6 Current Focus & Strategies
16.2.7 Threat from competition
16.2.8 SWOT Analysis
16.3 Twist Bioscience
16.3.1 Key Facts
16.3.2 Financial Overview
16.3.3 Product Benchmarking
16.3.4 Recent Developments
16.3.5 Winning Imperatives
16.3.6 Current Focus & Strategies
16.3.7 Threat from competition
16.3.8 SWOT Analysis
16.4 Genscript 
16.4.1 Key Facts
16.4.2 Financial Overview
16.4.3 Product Benchmarking
16.4.4 Recent Developments
16.4.5 Winning Imperatives
16.4.6 Current Focus & Strategies
16.4.7 Threat from competition
16.4.8 SWOT Analysis
16.5 Biocytogen
16.5.1 Key Facts
16.5.2 Financial Overview
16.5.3 Product Benchmarking
16.5.4 Recent Developments
16.5.5 Winning Imperatives
16.5.6 Current Focus & Strategies
16.5.7 Threat from competition
16.5.8 SWOT Analysis
16.6 Sartorius AG
16.6.1 Key Facts
16.6.2 Financial Overview
16.6.3 Product Benchmarking
16.6.4 Recent Developments
16.6.5 Winning Imperatives
16.6.6 Current Focus & Strategies
16.6.7 Threat from competition
16.6.8 SWOT Analysis
16.7 Danaher Corporation
16.7.1 Key Facts
16.7.2 Financial Overview
16.7.3 Product Benchmarking
16.7.4 Recent Developments
16.7.5 Winning Imperatives
16.7.6 Current Focus & Strategies
16.7.7 Threat from competition
16.7.8 SWOT Analysis
16.8 Fairjourney Biologics S.A
16.8.1 Key Facts
16.8.2 Financial Overview
16.8.3 Product Benchmarking
16.8.4 Recent Developments
16.8.5 Winning Imperatives
16.8.6 Current Focus & Strategies
16.8.7 Threat from competition
16.8.8 SWOT Analysis
16.9 Creative Biolabs
16.9.1 Key Facts
16.9.2 Financial Overview
16.9.3 Product Benchmarking
16.9.4 Recent Developments
16.9.5 Winning Imperatives
16.9.6 Current Focus & Strategies
16.9.7 Threat from competition
16.9.8 SWOT Analysis
16.10 Charles River Laboratories
16.10.1 Key Facts
16.10.2 Financial Overview
16.10.3 Product Benchmarking
16.10.4 Recent Developments
16.10.5 Winning Imperatives
16.10.6 Current Focus & Strategies
16.10.7 Threat from competition
16.10.8 SWOT Analysis

LIST OF TABLES

TABLE 1 Global Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 2 Global Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 3 Global Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 4 Global Antibody Discovery Market Revenue, By Geography, 2021 – 2031 (USD Billion)
TABLE 5 North America Antibody Discovery Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 6 North America Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 7 North America Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 8 North America Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 9 US Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 10 US Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 11 US Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 12 Canada Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 13 Canada Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 14 Canada Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 15 Mexico Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 16 Mexico Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 17 Mexico Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 18 Europe Antibody Discovery Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 19 Europe Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 20 Europe Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 21 Europe Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 22 Germany Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 23 Germany Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 24 Germany Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 25 France Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 26 France Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 27 France Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 28 U.K. Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 29 U.K. Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 30 U.K. Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 31 Spain Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 32 Spain Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 33 Spain Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 34 Italy Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 35 Italy Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 36 Italy Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 37 Russia Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 38 Russia Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 39 Russia Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 40 Rest of Europe Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 41 Rest of Europe Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 42 Rest of Europe Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 43 Asia-Pacific Antibody Discovery Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 44 Asia-Pacific Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 45 Asia-Pacific Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 46 Asia-Pacific Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 47 China Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 48 China Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 49 China Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 50 Japan Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 51 Japan Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 52 Japan Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 53 India Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 54 India Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 55 India Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 56 South Korea Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 57 South Korea Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 58 South Korea Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 59 Rest of Asia-Pacific Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 60 Rest of Asia-Pacific Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 61 Rest of Asia-Pacific Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 62 Middle East and Africa Antibody Discovery Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 63 Middle East and Africa Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 64 Middle East and Africa Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 65 Middle East and Africa Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 66 GCC Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 67 GCC Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 68 GCC Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 69 North Africa Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 70 North Africa Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 71 North Africa Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 72 South Africa Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 73 South Africa Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 74 South Africa Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 75 Rest of Middle East & Africa Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 76 Rest of Middle East & Africa Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 77 Rest of Middle East & Africa Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 78 Latin America Antibody Discovery Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 79 Latin America Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 80 Latin America Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 81 Latin America Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 82 Brazil Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 83 Brazil Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 84 Brazil Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 85 Argentina Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 86 Argentina Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 87 Argentina Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 88 Rest of Latin America Antibody Discovery Market Revenue, By Technique, 2021 – 2031 (USD Billion)
TABLE 89 Rest of Latin America Antibody Discovery Market Revenue, By Antibody Type, 2021 – 2031 (USD Billion)
TABLE 90 Rest of Latin America Antibody Discovery Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 91 Company Market Ranking
TABLE 92 Regional Footprint
TABLE 93 Product Benchmarking
TABLE 94 Recent Developments
TABLE 95 Winning Imperatives 

LIST OF FIGURES

FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global Antibody Discovery Market 2021-2031 (USD Billion)
FIG. 4 Global Antibody Discovery Market Geographical Analysis (CAGR %)
FIG. 5 Global Antibody Discovery Absolute Market Opportunity (USD Billion)
FIG. 6 Global Antibody Discovery Market Attractiveness (USD Billion)
FIG. 7 Global Antibody Discovery Market, By Technique, 2021-2031 (USD Billion)
FIG. 8 Global Antibody Discovery Market, By Antibody Type, 2021-2031 (USD Billion)
FIG. 9 Global Antibody Discovery Market, By End User, 2021-2031 (USD Billion)
FIG. 10 Research Methodology
FIG. 11 Research Process
FIG. 12 Bottom-Up Approach
FIG. 13 Top-Bottom Approach
FIG. 14 Market Dynamics Overview
FIG. 15 Porter's Five Forces Analysis
FIG. 16 Value Chain Analysis
FIG. 17 Macroeconomic Analysis
FIG. 18 Global Antibody Discovery Market Revenue Share, By Technique, 2023 and 2031 (%)
FIG. 19 Global Antibody Discovery Market Revenue Share, By Antibody Type, 2023 and 2031 (%)
FIG. 20 Global Antibody Discovery Market Revenue Share, By End User, 2023 and 2031 (%)
FIG. 21 Global Antibody Discovery Market Revenue Share, By Geographic Regions, 2023 and 2031 (%)
FIG. 22 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 23 North America Antibody Discovery Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 24 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 25 Europe Antibody Discovery Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 26 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 27 Asia-Pacific Antibody Discovery Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 28 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 29 Middle East & Africa Antibody Discovery Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 30 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 31 Latin America Antibody Discovery Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 32 Key Strategic Development
FIG. 33 Key Facts
FIG. 34 Financial Overview
FIG. 35 SWOT Analysis